Clinical Trial Update: PK and Safety Study of Natroba Topical Suspension 0.9% in Subjects 1 Month to 3 Years 11 Months of Age With Scabies [Phase 4]

View source ↗

Summary

Phase 4 pharmacokinetic and safety study of Natroba 0.9% topical suspension in children aged 1 month to 3 years 11 months with scabies; the current status of th…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Scabies

Drugs mentioned

• Natroba Topical Suspension 0.9% (permethrin)

Snippet

Sponsor: Cipher Pharmaceuticals Inc. | Conditions: Scabies | Phase 4 | Status: UNKNOWN